Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival

Abstract Prostate cancer (PCa) is one of the most common malignancies associated with bone metastases, and palliative radiation therapy (RT) is an effective treatment option. A total of 2641 patients were identified with PCa and bone metastases at diagnosis from 2010 to 2014 in the NCDB. Fractionati...

Full description

Saved in:
Bibliographic Details
Main Authors: Benjamin W. Fischer‐Valuck, Brian C. Baumann, Anthony Apicelli, Yuan James Rao, Michael Roach, Mackenzie Daly, Maria C. Dans, Patrick White, Jessika Contreras, Lauren Henke, Hiram Gay, Jeff M. Michalski, Christopher Abraham
Format: Article
Language:English
Published: Wiley 2018-09-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1655
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849735830904504320
author Benjamin W. Fischer‐Valuck
Brian C. Baumann
Anthony Apicelli
Yuan James Rao
Michael Roach
Mackenzie Daly
Maria C. Dans
Patrick White
Jessika Contreras
Lauren Henke
Hiram Gay
Jeff M. Michalski
Christopher Abraham
author_facet Benjamin W. Fischer‐Valuck
Brian C. Baumann
Anthony Apicelli
Yuan James Rao
Michael Roach
Mackenzie Daly
Maria C. Dans
Patrick White
Jessika Contreras
Lauren Henke
Hiram Gay
Jeff M. Michalski
Christopher Abraham
author_sort Benjamin W. Fischer‐Valuck
collection DOAJ
description Abstract Prostate cancer (PCa) is one of the most common malignancies associated with bone metastases, and palliative radiation therapy (RT) is an effective treatment option. A total of 2641 patients were identified with PCa and bone metastases at diagnosis from 2010 to 2014 in the NCDB. Fractionation scheme was designated as short course ([SC‐RT]: 8 Gy in 1 fraction and 20 Gy in 5 fractions) vs long course ([LC‐RT]: 30 Gy in 10 fractions and 37.5 Gy in 15 fractions). Patient characteristics were correlated with fractionation scheme using logistic regression. Overall survival was analyzed using the Kaplan‐Meier method, log‐rank test, Cox proportional hazards models, and propensity score‐matched analyses. A total of 2255 (85.4%) patients were included in the LC‐RT group and 386 (14.6%) patients in the SC‐RT group. SC‐RT was more common in patients over 75 years age (odds ratio [OR]: 1.70, 95% confidence interval [CI] 1.32‐2.20), treatment at an academic center (OR: 1.76, 1.20‐2.57), living greater than 15 miles distance to treatment facility (OR: 1.38, 1.05‐1.83), treatment to the rib (OR: 2.99, 1.36‐6.60), and in 2014 (OR: 1.73, 1.19‐2.51). RT to the spine was more commonly long course (P < .0001). In the propensity‐matched cohort, LC‐RT was associated with improved OS (P < .0001), but no OS difference was observed between 37.5 Gy and either 8 Gy in one fraction or 20 Gy in 5 fractions (P > .5). LC‐RT remains the most common treatment fractionation scheme for palliative bone metastases in PCa patients. Use of palliative SC‐RT is increasing, particularly in more recent years, for older patients, treatment at academic centers, and with increasing distance from a treatment center.
format Article
id doaj-art-5966954b0dbf4d42897656f4d02fa5d2
institution DOAJ
issn 2045-7634
language English
publishDate 2018-09-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-5966954b0dbf4d42897656f4d02fa5d22025-08-20T03:07:27ZengWileyCancer Medicine2045-76342018-09-01794240425010.1002/cam4.1655Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survivalBenjamin W. Fischer‐Valuck0Brian C. Baumann1Anthony Apicelli2Yuan James Rao3Michael Roach4Mackenzie Daly5Maria C. Dans6Patrick White7Jessika Contreras8Lauren Henke9Hiram Gay10Jeff M. Michalski11Christopher Abraham12Department of Radiation Oncology Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USADivision of Hospice & Palliative Medicine Department of Hospital Medicine Washington University School of Medicine St. Louis MO USADivision of Hospice & Palliative Medicine Department of Hospital Medicine Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USADepartment of Radiation Oncology Washington University School of Medicine St. Louis MO USAAbstract Prostate cancer (PCa) is one of the most common malignancies associated with bone metastases, and palliative radiation therapy (RT) is an effective treatment option. A total of 2641 patients were identified with PCa and bone metastases at diagnosis from 2010 to 2014 in the NCDB. Fractionation scheme was designated as short course ([SC‐RT]: 8 Gy in 1 fraction and 20 Gy in 5 fractions) vs long course ([LC‐RT]: 30 Gy in 10 fractions and 37.5 Gy in 15 fractions). Patient characteristics were correlated with fractionation scheme using logistic regression. Overall survival was analyzed using the Kaplan‐Meier method, log‐rank test, Cox proportional hazards models, and propensity score‐matched analyses. A total of 2255 (85.4%) patients were included in the LC‐RT group and 386 (14.6%) patients in the SC‐RT group. SC‐RT was more common in patients over 75 years age (odds ratio [OR]: 1.70, 95% confidence interval [CI] 1.32‐2.20), treatment at an academic center (OR: 1.76, 1.20‐2.57), living greater than 15 miles distance to treatment facility (OR: 1.38, 1.05‐1.83), treatment to the rib (OR: 2.99, 1.36‐6.60), and in 2014 (OR: 1.73, 1.19‐2.51). RT to the spine was more commonly long course (P < .0001). In the propensity‐matched cohort, LC‐RT was associated with improved OS (P < .0001), but no OS difference was observed between 37.5 Gy and either 8 Gy in one fraction or 20 Gy in 5 fractions (P > .5). LC‐RT remains the most common treatment fractionation scheme for palliative bone metastases in PCa patients. Use of palliative SC‐RT is increasing, particularly in more recent years, for older patients, treatment at academic centers, and with increasing distance from a treatment center.https://doi.org/10.1002/cam4.1655metastatic prostate cancerNational Cancer Databasepalliative radiation
spellingShingle Benjamin W. Fischer‐Valuck
Brian C. Baumann
Anthony Apicelli
Yuan James Rao
Michael Roach
Mackenzie Daly
Maria C. Dans
Patrick White
Jessika Contreras
Lauren Henke
Hiram Gay
Jeff M. Michalski
Christopher Abraham
Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival
Cancer Medicine
metastatic prostate cancer
National Cancer Database
palliative radiation
title Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival
title_full Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival
title_fullStr Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival
title_full_unstemmed Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival
title_short Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital‐based analysis of patterns of care, RT fractionation scheme, and overall survival
title_sort palliative radiation therapy rt for prostate cancer patients with bone metastases at diagnosis a hospital based analysis of patterns of care rt fractionation scheme and overall survival
topic metastatic prostate cancer
National Cancer Database
palliative radiation
url https://doi.org/10.1002/cam4.1655
work_keys_str_mv AT benjaminwfischervaluck palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT briancbaumann palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT anthonyapicelli palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT yuanjamesrao palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT michaelroach palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT mackenziedaly palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT mariacdans palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT patrickwhite palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT jessikacontreras palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT laurenhenke palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT hiramgay palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT jeffmmichalski palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival
AT christopherabraham palliativeradiationtherapyrtforprostatecancerpatientswithbonemetastasesatdiagnosisahospitalbasedanalysisofpatternsofcarertfractionationschemeandoverallsurvival